Diversified Healthcare Trust (NASDAQ:DHC) CEO buys 20,000 shares at $4.886

Rhea-AI Filing Summary

Diversified Healthcare Trust reported that its President, CEO and Director Christopher J. Bilotto purchased 20,000 common shares of beneficial interest on 12/15/2025 at a weighted average price of $4.886 per share, in multiple transactions priced between $4.88 and $4.89.

After these purchases, he beneficially owns 266,284.908 DHC shares directly, which includes 385.018 shares acquired through a dividend reinvestment plan since his last Section 16 filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bilotto Christopher J.

(Last) (First) (Middle)

C/O THE RMR GROUP LLC

TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)

NEWTON MA 02458

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	12/15/2025		P		20,000	A	$4.886(1)	266,284.908(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.89 per share. Mr. Bilotto undertakes to provide to Diversified Healthcare Trust (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. Includes 385.018 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Mr. Bilotto.

	/s/ Christopher J. Bilotto	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DHC report for Christopher J. Bilotto?

Christopher J. Bilotto, President, CEO and Director of Diversified Healthcare Trust (DHC), reported buying 20,000 common shares of beneficial interest on 12/15/2025.

At what price did Christopher J. Bilotto buy DHC shares?

He bought the 20,000 DHC shares at a weighted average price of $4.886 per share, with individual trades executed between $4.88 and $4.89 per share.

How many DHC shares does Christopher J. Bilotto now beneficially own?

Following the reported transactions, Christopher J. Bilotto beneficially owns 266,284.908 DHC shares held directly.

Does Bilotto’s DHC stake include shares from a dividend reinvestment plan?

Yes. His reported holdings include 385.018 shares that were acquired under a dividend reinvestment plan since his last Section 16 filing.

What is Christopher J. Bilotto’s role at Diversified Healthcare Trust (DHC)?

Christopher J. Bilotto is a Director of Diversified Healthcare Trust and serves as its President and Chief Executive Officer.

Were Bilotto’s DHC share purchases made in a single trade or multiple trades?

The filing states that the 20,000 DHC shares were purchased in multiple transactions at prices ranging from $4.88 to $4.89 per share.